Changes in protein expression in two cholangiocarcinoma cell lines undergoing formation of multicellular tumor spheroids in vitro
- PMID: 25756965
- PMCID: PMC4355290
- DOI: 10.1371/journal.pone.0118906
Changes in protein expression in two cholangiocarcinoma cell lines undergoing formation of multicellular tumor spheroids in vitro
Abstract
Epithelial-to-Mesenchymal Transition (EMT) is relevant in malignant growth and frequently correlates with worsening disease progression due to its implications in metastases and resistance to therapeutic interventions. Although EMT is known to occur in several types of solid tumors, the information concerning tumors arising from the epithelia of the bile tract is still limited. In order to approach the problem of EMT in cholangiocarcinoma, we decided to investigate the changes in protein expression occurring in two cell lines under conditions leading to growth as adherent monolayers or to formation of multicellular tumor spheroids (MCTS), which are considered culture models that better mimic the growth characteristics of in-vivo solid tumors. In our system, changes in phenotypes occur with only a decrease in transmembrane E-cadherin and vimentin expression, minor changes in the transglutaminase protein/activity but with significant differences in the proteome profiles, with declining and increasing expression in 6 and in 16 proteins identified by mass spectrometry. The arising protein patterns were analyzed based on canonical pathways and network analysis. These results suggest that significant metabolic rearrangements occur during the conversion of cholangiocarcinomas cells to the MCTS phenotype, which most likely affect the carbohydrate metabolism, protein folding, cytoskeletal activity, and tissue sensitivity to oxygen.
Conflict of interest statement
Figures





Similar articles
-
Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma.Int J Oncol. 2012 Aug;41(2):573-82. doi: 10.3892/ijo.2012.1499. Epub 2012 May 29. Int J Oncol. 2012. PMID: 22664794
-
Overexpression of epithelial-mesenchymal transition-related markers according to cell dedifferentiation: clinical implications as an independent predictor of poor prognosis in cholangiocarcinoma.Hum Pathol. 2012 Dec;43(12):2360-70. doi: 10.1016/j.humpath.2012.07.004. Epub 2012 Oct 16. Hum Pathol. 2012. PMID: 23084587
-
Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.Biochem Biophys Res Commun. 2014 Mar 28;446(1):54-60. doi: 10.1016/j.bbrc.2014.02.050. Epub 2014 Feb 22. Biochem Biophys Res Commun. 2014. PMID: 24565842
-
Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids.J Exp Clin Cancer Res. 2017 Aug 3;36(1):102. doi: 10.1186/s13046-017-0570-9. J Exp Clin Cancer Res. 2017. PMID: 28774341 Free PMC article. Review.
-
Mass Spectrometry Analyses of Multicellular Tumor Spheroids.Proteomics Clin Appl. 2018 May;12(3):e1700124. doi: 10.1002/prca.201700124. Epub 2018 Feb 9. Proteomics Clin Appl. 2018. PMID: 29227035 Review.
Cited by
-
MSC-derived exosomes attenuate hepatic fibrosis in primary sclerosing cholangitis through inhibition of Th17 differentiation.Asian J Pharm Sci. 2024 Feb;19(1):100889. doi: 10.1016/j.ajps.2024.100889. Epub 2024 Feb 12. Asian J Pharm Sci. 2024. PMID: 38419761 Free PMC article.
-
Evolution of the Experimental Models of Cholangiocarcinoma.Cancers (Basel). 2020 Aug 17;12(8):2308. doi: 10.3390/cancers12082308. Cancers (Basel). 2020. PMID: 32824407 Free PMC article. Review.
-
Multi-omics analysis defines 5-fluorouracil drug resistance in 3D HeLa carcinoma cell model.Bioresour Bioprocess. 2021 Dec 23;8(1):135. doi: 10.1186/s40643-021-00486-z. Bioresour Bioprocess. 2021. PMID: 38650282 Free PMC article.
-
Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma.Hepatology. 2021 Jul;74(1):491-502. doi: 10.1002/hep.31653. Epub 2021 Jun 4. Hepatology. 2021. PMID: 33222247 Free PMC article. Review.
-
3D cancer models: One step closer to in vitro human studies.Front Immunol. 2023 Apr 11;14:1175503. doi: 10.3389/fimmu.2023.1175503. eCollection 2023. Front Immunol. 2023. PMID: 37114038 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical